Back to Woodline Partners LP Woodline Partners LP

SNDXSNDX
Showing 8 of 21 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in SYNDAX PHARMACEUTICALS INC

Woodline Partners LP holds 1.3M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $27.3M as of 2026-Q2. SNDX represents 0.1% of Woodline Partners LP's portfolio.

Current Value

$27.3M

Current Shares

1.3M

Total Value Change

-$9.2M

Total Shares Change

-645,272

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.3M
0.0%
$27.3M0.1%$21.86
0
2026-Q1
Increased
1.3M
+0.0%
$29.2M0.1%$21.40
34
2025-Q4
Decreased
1.3M
-19.3%
$26.3M0.1%$20.74
0
2025-Q3
Decreased
1.6M
-18.1%
$23.9M0.1%$15.56
0
2025-Q2
Increased
1.9M
+0.1%
$17.7M0.1%$9.04
28
2025-Q1
Unchanged
1.9M
0.0%
$23.2M0.2%$13.18
0
2024-Q4
Decreased
1.9M
-0.2%
$25M0.2%$12.52
0
2024-Q3
Increased
1.9M
+22.7%
$36.5M0.3%$18.89
42

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used